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In Brief
Necroptosis plays a role in restricting
propagation of certain viruses. Huang
et al. find thatmurine but not humanRIP1/
RIP3 directly senses HSV-1 ICP6 to
initiate necroptosis. These findings
suggest that necroptosis is a host
defense mechanism against HSV-1 and
that HSV-1 has evolved to escape
necroptosis-mediated restriction in
humans.
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Necroptosis is a form of programmed necrosis that is
mediated by signaling complexes containing the re-
ceptor-interacting protein 3 (RIP3) and RIP1 kinases.
We show that RIP3 and its interactionwith the herpes
simplex virus type 1 (HSV-1) protein ICP6 triggers
necroptosis in infected mouse cells and limits viral
propagation in mice. ICP6 interacts with RIP1/RIP3
through its RHIM domain and forms dimers/oliog-
mers by its C-terminal R1 domain. These binding
events result in RIP1-RIP3 hetero- and RIP3-RIP3
homo-interactions and subsequent necroptosis of
HSV-1-infected mouse cells. However, ICP6 RHIM
cannot trigger necroptosis and even inhibits TNF-
induced necroptosis in human cells. As the RHIM
domain in murine cytomegalovirus protein vIRA
can inhibit necroptosis in both human and mouse
cells, these data suggest that both viral and host
RHIM sequences determine whether the virus-
host RHIM interaction is pro- or anti-necroptotic
and that some viruses may evolve to escape this re-
striction.
INTRODUCTION
Like the production of anti-viral cytokines such as interferon,
death of virus-infected cells is also a host defense mechanism
to control viral spread (Mocarski et al., 2012). Apoptosis de-
pends on activation of caspases, and many viruses encode
caspase inhibitors to suppress infection-induced apoptosis. Ne-
crosis can also be used by host to clear invading pathogens
(Han et al., 2011; Mocarski et al., 2012). Necroptosis is a type
of programmed necrosis mediated by signaling complexes
called necrosomes (Christofferson and Yuan, 2010; Han et al.,
2011; Vandenabeele et al., 2010). The core components of ne-
crosomes are receptor-interacting protein kinase 1 (RIP1) (Holler
et al., 2000) and RIP3 (Cho et al., 2009; He et al., 2009; ZhangCell Host &et al., 2009), both of which are protein kinases containing an
RIP homotypic interaction motif (RHIM). Our knowledge of
necroptosis was mostly obtained by studying tumor necrosis
factor-a (TNF-a)-induced necroptosis. TNF induces formation
of necrosomes containing RIP1, RIP3, caspase-8, and adaptors
TRADD and FADD in cells with high levels of RIP3 expression
and/or caspase-8 inhibition (Han et al., 2011; Vandenabeele
et al., 2010). Phosphorylation of RIP3 in necrosomes leads to
the recruitment of mixed-lineage kinase domain-like protein
(MLKL) (Sun et al., 2012; Zhao et al., 2012). The interaction
with RIP3 leads to MLKL phosphorylation and translocation to
the plasma membrane, which is followed by an ion influx and
cell membrane disruption (Cai et al., 2014; Chen et al., 2014;
Dondelinger et al., 2014; Wang et al., 2014a).
RIP3-mediated necrosis plays an important role in immune de-
fense against some viruses, including vaccinia virus and murine
cytomegalovirus (MCMV) (Cho et al., 2009; Upton et al., 2010).
HSV-1 is a double-stranded DNA virus that has evolved nu-
merous strategies to infect a wide range of hosts, including hu-
man and mice (Karasneh and Shukla, 2011). In comparison
with in human cells, the replication of most HSV-1 strains is
less efficient in mouse cells (Lopez, 1975). ICP6, also known as
HSV-1 ribonucleotide reductase (RNR) subunit 1 (R1), is en-
coded by the UL39 gene of HSV-1. RNR acts to synthesize the
four deoxyribonucleotides required for DNA synthesis. With an
RHIM-like domain (Lembo and Brune, 2009), ICP6 has been
reported to be important for protecting HSV-1-infected cells
against death receptor (DR)-mediated apoptosis by interacting
with caspase-8 (Dufour et al., 2011).
We have examined the propagation of several viruses in RIP3
knockout (KO) murine cells and found that HSV-1 replication was
markedly elevated after RIP3 deletion. We unveiled that this
elevation was due to the lack of necroptosis in HSV-1-infected
RIP3 KO cells. Further mechanistic studies revealed that
HSV-1 protein ICP6 directly interacts with RIP1 andRIP3 through
its RHIM domain, and these interactions lead to RIP1-RIP3 and
RIP3-RIP3 interaction and subsequent necroptosis. Our findings
suggest that the previously observed restriction of HSV-1 in
mouse cells may be partly due to RIP3-mediated necroptosis
and provide insight into RIP3-dependent necrosis in sensing
and defending certain viruses.Microbe 17, 229–242, February 11, 2015 ª2015 Elsevier Inc. 229
RESULTS
RIP3 Is a Cellular Factor that Restricts HSV-1
Propagation
In consideration of the role of RIP3 in MCMV-induced necropto-
sis (Upton et al., 2010), we examined the role of cellular RIP3 in
the propagation of a few other viruses. Wild-type (WT) and
RIP3 KO cell lines from murine fibroblast cell line L929 (Chen
et al., 2014) were infected with the HSV-1 KOS strain (hereinafter
referred to as HSV-1), VSV, or NDV. HSV-1 (Figure 1A), but not
VSV or NDV (Figures S1A and S1B), propagates much more in
RIP3 KO L929 cells than in WT L929 cells. The titer of HSV-1 in
RIP3 KO L929 cells was markedly higher than that in WT L929
cells after the cells were infected with HSV-1 (1 moi) for 24 hr
or longer time. HSV-1 propagation was restricted when the
expression of RIP3 was reconstituted (Figure 1B). Consistently,
the accumulation of glycoprotein D (gD), a HSV-1 envelope
glycoprotein, in RIP3 KO cells was much higher than that in
WT L929 cells (Figure 1C). This phenotype was reversed when
RIP3 expression was reconstituted in RIP3 KO cells (Figure 1D).
We also used 1 moi GFP-HSV-1 (F strain), a GFP-tagged HSV-1,
to infect the cells and observed that the GFP intensity ofRIP3KO
cells was much higher than that of WT L929 cells (Figure 1E).
Reconstitution of RIP3 expression suppressed GFP-HSV-1
propagation in RIP3 KO cells (Figure 1F). The restriction of
HSV-1 propagation by endogenous or ectopically expressed
RIP3 was also observed in other cell lines, such as mouse em-
bryonic fibroblast (MEF) and NIH 3T3 cells (Figures S1C and
S1D). Collectively, these data demonstrate that RIP3 restricts
HSV-1 propagation in some cell lines.
HSV-1 Infection Leads to RIP3-Dependent Cell Death
To determine how RIP3 restricts HSV-1, we investigated the role
of RIP3 from the following three aspects: HSV-1 entry, HSV-1
genomic DNA replication, and HSV-1 spreading. To analyze
cell penetration by HSV-1, WT and RIP3 KO L929 cells were in-
fected with or without HSV-1 at 200 moi for 2 hr in the presence
of cycloheximide (CHX) to block the synthesis of proteins
including HSV-1 proteins. HSV-1 genomic DNA levels in the in-
fected cells were analyzed by measuring the levels of HSV-1
gD, ICP22, and ICP47 DNA with qPCR, and no difference was
found betweenWT andRIP3KO cells (Figure 2A). We also exam-
ined the amounts of HSV-1 tegument protein VP16, an HSV-1
virion protein internalized into infected cells, and found that the
amounts of VP16 were the same in WT and RIP3 KO L929 cells
(Figure 2B). To analyze HSV-1 genomic DNA replication, HSV-1
genomic DNA level within the first life cycle of HSV-1 infection (0–
10 hr) wasmeasured. HSV-1-infectedRIP3KOL929 cells did not
exhibit higher HSV-1 genomic DNA replication efficiency in com-
parison with WT cells (Figure 2C). Thus, RIP3 deletion does not
affect HSV-1 entry into the cells or genomic DNA replication.
We then used GFP-HSV-1 to monitor the infection of HSV-1 in
WT and RIP3 KO L929 cells (Figure 2D). At 12 hr post-infection,
the numbers of infected cells (GFP+ cells) are the same in the two
cell lines. But at later time points, the number of GFP+ RIP3 KO
L929 cells continued to increase while that of GFP+ WT L929
cells declined. We monitored the viability of GFP+ WT and
RIP3 KO L929 cells by time-lapse fluorescence microscopy in
the presence of propidium iodide (PI), which can stain dead cells230 Cell Host & Microbe 17, 229–242, February 11, 2015 ª2015 Else(Figure 2E). Fifty GFP+ cells in each of the two cell lines had been
monitored for 42 hr. All of the GFP+ WT L929 cells turned PI pos-
itive while only 3 of the 50 GFP+ RIP3 KO cells became so. The
animation of time-lapse pictures showed that the HSV-1-in-
fected (GFP+) WT L929 cells became round and finally ruptured
(PI positive) after GFP intensity reached a certain level, whereas
GFP+ RIP3 KO L929 cells were still viable up to 42 hr after infec-
tion (Movies S1 and S2), suggesting that the accumulation of
viral proteins might be required for HSV-1-induced cell death.
Although we observed death of HSV-1-infected WT L929 cells
(Figure 2E), we did not see cell loss. A possible explanation is
that 1 moi virus only infected a small amount of cells, and the
cell loss was soon counterbalanced by the proliferation of
newborn cells. To confirm that HSV-1 infection can induce
RIP3-dependent necrosis in L929 cells, we treated WT and
RIP3 KO L929 cells with high-dose (20 moi) HSV-1, which would
result in much higher infection efficiency than 1 moi HSV-1. The
infection of WT but not RIP3 KO L929 cells led to cell loss (Fig-
ure 2F). The cell death was caspase independent, since pan-
caspase inhibitor zVAD did not inhibit but rather enhanced
HSV-1-induced cell death (Figure 2G), indicating that the cell
death was not caused by apoptosis. Taking into consideration
the morphology of dying cells, the requirement of RIP3, and
the independence of caspase, HSV-1-induced cell death is nec-
roptosis. Similar data were obtained in other murine cell lines,
such as MEF and NIH 3T3 cells (Figures S2A and S2B).
Since human is a natural host of HSV-1, we examined whether
RIP3 also plays a role in suppressing HSV-1 propagation in hu-
man cells. HT-29 is a human cell line that expresses RIP3 and un-
dergoes necroptosis upon TNF plus zVAD plus Smac mimetic
stimulation (He et al., 2009) (Figure S2C).We infectedHT-29 cells
with HSV-1 but did not detect RIP3-dependent necroptosis (Fig-
ure S2D). Thus, HSV-1-induced necroptosis might be species
dependent.
We also examined the viability of L929 cells after VSV or NDV
infection. VSV induced L929 cell death whereas NDV infection
did not affect the viability of L929 cells. The levels of VSV-
induced cell death were comparable in WT and RIP3 KO cells
(Figure S2E). Gene deletion of RIP3 also did not affect the
viability of NDV-infected L929 cells (Figure S2F). Together with
the results of viral replication shown in Figures S1A and S1B,
these data indicate that RIP3 is involved in murine cell defense
against HSV-1 but not VSV or NDV.
HSV-1-Induced Necroptosis Is Independent of TNFR1,
Partially Dependent on RIP1, and Fully Dependent on
RIP3 and MLKL
Since HSV-1 infection induces inflammatory cytokines including
TNF, which can induce RIP3-dependent necroptosis via TNF re-
ceptor 1, we ought to clarify whether TNF plays any roles in HSV-
1-induced necroptosis. We generated a TNFR1 KO L929 cell line
by CRISPR/Cas9 gene editing technique (Figure S3A), and the
loss of TNFR1’s function was confirmed by treating the cells
with TNF-a, zVAD, or TNF-a plus zVAD (Figure S3B). WT and
TNFR1 KO L929 cells were infected with 20 moi HSV-1, and their
viability was measured from 0 to 24 hr (Figure 3A). The cell
viability of TNFR1 KO L929 cells only increased slightly,
excluding the possibility that HSV-1-induced necroptosis is an
autocrine effect of TNF. To examine whether other cytokinesvier Inc.
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Figure 1. RIP3 Is a Cellular Factor that Restricts HSV-1 Propagation
(A) RIP3 deficiency leads to elevation of HSV-1 propagation. WT and RIP3 KO L929 cells were infected with HSV-1 (1 moi) for 2 hr, washed twice with PBS, and
replaced with fresh medium. Cells together with the supernatants were harvested at 18, 24, and 36 hr after infection. After three repeated freeze-thaw cycles, the
samples were centrifuged at 6,000 rpm for 30 min, and then the supernatants were collected to determine the viral titer by a standard viral plaque assay. pfu,
plaque-forming units.
(B) Reconstitution of RIP3 expression in RIP3 KO L929 cells restores the restriction in HSV-1 replication. RIP3-reconstituted RIP3 KO L929 cells and the control
cells were infected with HSV-1 (1 moi) over the indicated time periods. The HSV-1 viral titers were measured as described in (A).
(C) The accumulation of HSV-1 gD in RIP3 KO L929 cells is higher than that in WT cells. WT and RIP3 KO L929 cells were infected with HSV-1 (1 moi) over the
indicated time periods, and the whole-cell lysates were subjected to SDS-PAGE and analyzed by immunoblotting with the indicated antibodies. SE, short
exposure; LE, long exposure.
(D) The same as in (C), except RIP3-reconstituted RIP3 KO cells and control cells were used.
(E) WT L929 cells are more resistant to GFP-HSV-1 infection compared with RIP3 KO L929 cells. WT and RIP3 KO L929 cells were infected with GFP-HSV-1 (1
moi) for 42 hr and then imaged using a fluorescent microscope. The top panel is light microscopy and the lower panel is fluorescent microscopy (GFP). Scale bar,
5 mm.
(F) The same as in (E), except RIP3-reconstituted RIP3 KO cells and control cells were used.
Data are represented as mean ± SD of triplicate samples (A and B), and similar results were obtained in 3–5 independent experiments (A–F). See also Figure S1.were involved, we collected conditional media from the cell cul-
ture of L929 at different time points after HSV-1 infection,
removed HSV-1 by ultracentrifugation, and then used these con-
ditional media to treat newly prepared L929 cells. The condi-Cell Host &tional media did not induce necroptosis (Figure S3C). Since
RIP1 and MLKL are also important in TNF-induced necroptosis,
we determined whether RIP1 and MLKL were also involved in
HSV-1-induced necroptosis. RIP1 and MLKL KO L929 cellsMicrobe 17, 229–242, February 11, 2015 ª2015 Elsevier Inc. 231
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Figure 2. HSV-1 Infection Leads to RIP3-Dependent Cell Death
(A) Comparable HSV-1 entry into WT and RIP3 KO cells as indicated by HSV-1 genomic DNA levels. WT and RIP3 KO L929 cells were infected with or without
HSV-1 at 200moi for 2 hr in the presence of CHX (10 mg/ml). After beingwashed twicewith PBS, the cells were incubated with 0.25% trypsin and 0.025%EDTA for
5 min to remove viruses absorbed to the cell surface. Then the cells were harvested and genomic DNA was isolated for qPCR analysis of HSV-1 gD, ICP22, and
ICP47 genomic DNA levels.
(B) The experiment was performed similarly as in (A), except that the cell lysates were analyzed by immunoblotting with anti-VP16 antibody. *, non-specific band.
(C) HSV-1 does not replicate more in RIP3 KO cells during the first life cycle of infection. WT and RIP3 KO L929 cells were infected with HSV-1 (1 moi) for 2 hr,
washedwith PBS twice, and then changedwith freshmedium. At the indicated hours post-infection, cells were harvested and the genomic DNAwas extracted for
qPCR analysis of HSV-1 GD, ICP22, and ICP47 genomic DNA levels.
(D) WT andRIP3KO L929 cells were infected with GFP-HSV-1 (1 moi) over the indicated time periods, and the percentage of GFP-positive cells wasmeasured by
flow cytometry analysis.
(E) Infection of HSV-1 causes cell death. Shown are representative time-lapse images (merged) of WT and RIP3 KO L929 cells upon GFP-HSV-1 (1 moi) infection.
Cells were incubated with PI, infected with GFP-HSV-1, and then monitored by a fluorescent microscope. Green and red fluorescence denote GFP- (HSV-1
infected) and PI-positive (dead) cells, respectively. The arrows in the same color between the adjacent images point at the same cell. Scale bar, 2 mm.
(legend continued on next page)
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Figure 3. HSV-1-Induced Necroptosis Is In-
dependent of TNFR1, Partially Dependent
on RIP1, and Fully Dependent on RIP3 and
MLKL
(A) WT and TNFR1 KO L929 cells were infected
with high-dose (20 moi) HSV-1 over the indicated
time course, and cell viability was determined by PI
exclusion.
(B) WT, RIP3 KO, RIP1 KO, and MLKL KO L929
cells were infected with high-dose (20 moi) HSV-1
for 20 hr, and the cell viability was measured.
(C) Viability of WT, RIP3 KO, RIP1 KO, and MLKL
KO L929 cells upon HSV-1 (20 moi) plus zVAD
(20 mM) treatment over the indicated time periods.
(D) HSV-1-induced cell death is dependent on the
RIP3 RHIM domain, kinase activity, and T231/
S232 phosphorylation. RIP3 KO L929 cells that
were reconstitutedwith an empty vector, WTRIP3,
RHIM-mutated RIP3 (RHIMmut), kinase-dead RIP3
(D143N), or T231/S232 phosphorylation site-
mutated RIP3 (2A) were infected with high-dose
(20 moi) HSV-1 for 15 hr. The cell viability was
determined by PI exclusion (lower panel). Upper
panel shows the protein amounts of RIP3 mutants
expressed in RIP3 KO L929 cells.
(E) HSV-1 infection leads to RIP3 phosphorylation
on T231/S232 sites. RIP3 KO L929 cells stably
expressing Flag-tagged WT or T231A/S232A (2A)-
mutated RIP3 were infected with HSV-1 (20 moi)
for 0, 5, and 10 hr. The cell lysates were immuno-
precipitated with anti-Flag M2 beads, then the
phosphorylation state of RIP3 (P-RIP3) and RIP3
protein levels were determined by immunoblotting
with anti-phospho-RIP3 (T231/S232) and anti-
RIP3 antibodies, respectively.
(F) HSV-1 infection induces necrosome formation.
WT L929 cells were infected with high-dose (20
moi) HSV-1 for 0, 2, 4, 6, 8, and 10 hr, cells were
lysed to perform immunoprecipitation with anti-
RIP3 antibody-coupled protein A/G-sepharose
beads. The levels of RIP1 andMLKL in necrosome
were determined by immunoblotting with cor-
responding antibodies. IP, immunoprecipitates;
WCL, whole-cell lysates.
(G) MLKL is translocated to the plasmamembrane upon HSV-1 infection.MLKL KO L929 cells reconstituted with C-terminal 33 Flag-tagged MLKL were treated
with or without HSV-1 (20 moi) for 12 hr, and then immunostained for Flag and counterstained with DAPI. Among 52 monitored HSV-1 infected cells, 36 of them
exhibited MLKL plasma membrane localization as presented. Scale bar, 4 mm
Data are represented as mean ± SD of triplicate samples (A–D) and were representative of three independent experiments. See also Figure S3.were generated previously (Chen et al., 2014) (Figure S3D). Like
RIP3 KO cells, MLKL deficiency totally blocked HSV-1-induced
necroptosis (Figure 3B). However, RIP1 deletion only partially
blocked HSV-1-induced necroptosis (Figure 3B). To exclude
the possibility that the cell viability was affected by apoptosis,
we included zVAD throughout HSV-1 infection and obtained
the same results (Figure 3C). The viral propagation was also
elevated in the RIP1 KO or MLKL KO cells when the cells were
infected with 1 moi HSV-1 (Figure S3E). The partial dependence(F) High-dose HSV-1 infection leads to RIP3-dependent cell death.WT andRIP3K
periods, and the cell viability was determined by PI exclusion.
(G) zVAD does not inhibit but rather enhances HSV-1-induced cell death. WT and
(20 moi), or HSV-1 + zVAD for 14 hr, and the cell viability was analyzed by PI exc
Data are represented as mean ± SD of triplicate samples (A, C, D, F, and G), an
Figure S2 and Movies S1 and S2.
Cell Host &on RIP1 in HSV-1-induced necroptosis suggests that part of
HSV-1-induced necroptosis is through RIP1 to initiate RIP3-
dependent cell death.
RHIMdomain-dependent RIP1-RIP3 hetero-interaction, RIP3-
RIP3 homo-interaction, and RIP3’s autophosphorylation on its
T231/S232 are the sequential steps in TNF-induced necroptosis
(Chen et al., 2013; Cho et al., 2009; He et al., 2009; Wu et al.,
2014; Zhang et al., 2009). We expressed RHIM-mutated, ki-
nase-dead (D143N), T231/S232-mutated (T231A/S232A or 2A),O L929 cells were infected with high-dose (20moi) HSV-1 for the indicated time
RIP3 KO L929 cells were treated with medium (mock), zVAD (20 mM), HSV-1
lusion.
d similar results were obtained from three independent experiments. See also
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Figure 4. ICP6 Protein of HSV-1 Is a Trigger of Necroptosis
(A) Time-lapse effect of ActD on HSV-1-induced cell death. WT L929 cells were infected with HSV-1, and ActD was added at different time points after HSV-1
infection. At 15 hr post-infection, cells were harvested and cell viability was determined.
(B) Time-lapse effect of CHX on HSV-1-induced cell death. The experiment was performed as in (A), except that CHX was used.
(C) Identification of ICP6 as a binding protein with the highest affinity for RIP3 among HSV-1 viral proteins.RIP3KO L929 cells stably expressing Flag-tagged RIP3
were infected with HSV-1 (20 moi) for 8 hr; cells were lysed and subjected to immunoprecipitation with anti-Flag M2 beads. The eluted RIP3 complexes were then
analyzed by mass spectrometry to identify HSV-1 proteins in the RIP3 complex. The most abundant HSV-1 viral peptide in the RIP3 complex is shown.
(D) Sequence alignment of the RHIM domains of murine RIP1, RIP3, and HSV-1 ICP6. The four amino acid motifs crucial for RHIM function are boxed.
(E) ICP6 overexpression induces L929 cell death in an RHIM-dependentmanner, and zVAD cannot inhibit but rather enhances ICP6-induced cell death. L929 cells
were infected with lentivirus encoding nothing (Vector), ICP6, or RHIM-mutated ICP6 (ICP6 RHIMmut). zVAD was included in one of the ICP6 overexpression
samples. The cell viability was determined over the indicated time course (lower panel). The protein amounts of Flag-tagged WT and RHIM-mutated ICP6 were
shown in the upper panel.
(F) Viability of WT, RIP3 KO, RIP1 KO, and MLKL KO L929 cells upon ICP6 overexpression (lower panel). Upper panel showed ICP6 protein amounts.
(legend continued on next page)
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or WT RIP3 in RIP3 KO L929 cells and found that none of these
mutants can act as WT RIP3 to restore the sensitivity of RIP3 KO
L929 cells to HSV-1-induced necroptosis (Figure 3D), indicating
that RHIM domain, kinase activity, and T231/S232 phosphoryla-
tion of RIP3 are necessary for HSV-1-induced necroptosis. We
also showed that HSV-1 induces T231/S232 phosphorylation
(Figure 3E) and the RHIM mutant, kinase dead, or 2A mutant
cannot suppress HSV-1 propagation in RIP3 KO L929 cells
(Figure S3F).
HSV-1 infection induces necrosome formation, as RIP1 and
MLKLwere detected in the RIP3 immunocomplex fromL929 cells
infected with high-dose HSV-1 (Figure 3F). HSV-1 infection also
leads to MLKL translocation to plasma membrane (Figure 3G).
Summing up the above data, the mechanism of HSV-1-induced
necroptosis is the same as that of TNF-induced necroptosis
downstream of RIP3, whereas the upstream signaling pathways
of these two appear to be different.
HSV-1 Protein ICP6 Is a Trigger of Necroptosis
HSV-1 is a double-stranded DNA virus that might be sensed by
DAI (Takaoka et al., 2007), cyclic GMP-AMP synthase (cGAS)
(Sun et al., 2013), and possibly RIG-I (Choi et al., 2009). However,
HSV-1-induced necroptosis is not sensed by DAI, cGAS, and
RIG-I, because the sensitivities of DAI KO, cGAS KO, and
RIG-I KO L929 cells to HSV-1-induced necroptosis are the
same as that of WT L929 cells (Figure S4). Although DAI may
not sense dsDNA in other cells (Ishii et al., 2008), its deletion in
L929 cells abolished dsDNA-induced IFN-b expression (Fig-
ure S4F) (Takaoka et al., 2007).
Since HSV-1 viral proteins were accumulated in infected WT
cells before the rupture of plasma membrane (Movie S1), the
accumulation of HSV-1 viral protein(s) might be required for
HSV-1-induced necroptosis. To test this hypothesis, we treated
WT L929 with high-dose HSV-1 in the presence of actinomycin D
(ActD) to blockmRNA or CHX to block protein synthesis. Impres-
sively, ActD or CHX treatment completely blocked HSV-1-
induced necroptosis (Figures 4A and 4B), indicating that newly
synthesized protein(s) is/are required for HSV-1 to induce nec-
roptosis. As the deletion of cGAS impaired HSV-1-induced
type I interferon expression, but not cell death (Figures S4D
and S4G), we thought that HSV-1 viral protein(s), but not HSV-
1-induced cellular protein(s), is/are likely to be required for
HSV-1-induced necroptosis.
HSV-1 viral proteins can be divided into three sets that are pro-
duced in three sequential rounds of transcription: a (immediate
early), b (early), and g (late) proteins (Whitley and Roizman,(G) ICP6 overexpression induces necrosome formation and RIP3 phosphorylation
expressing 33 Flag-RIP3 were infected with lentiviral virus encoding nothing (Vec
zVAD for 30 hr. Whole-cell lysates were subjected to immunoprecipitation with
munoblotted with the indicated antibodies.
(H) ICP6 deletion in HSV-1 impairs HSV-1’s ability to induce L929 cell death. WT
(50 moi) over the indicated time periods, and cell viability was determined. A hi
expression of gD in ICP6D-infected RIP3 KO cells is at a level comparable with t
(I) ICP6 RHIMmutation (RHIMmut) in HSV-1 impairs HSV-1’s ability to induce L929
(20 moi) and ICP6 RHIMmut HSV-1 (20 moi) over the indicated time periods, and
(J) Viral titer in the samples described in (I) is shown. Samples were prepared as d
assay.
Data are represented as mean ± SD of triplicate wells (A, B, E, F, and H–J), and
Figures S4, S5, S6, and S7.
Cell Host &2001). Adding ActD at 3 hr or later time points after HSV-1 infec-
tion cannot block HSV-1-induced necroptosis (Figure 4A). Simi-
larly, addition of CHX at 4 hr or later time cannot block HSV-1-
induced necroptosis (Figure 4B). Considering that it costs certain
time for the drugs to reach their targets, the viral gene product(s)
that can induce necroptosis should be a or b protein(s). Because
HSV-1-induced necroptosis could result from directly targeting
RIP3, we performed mass spectrometry analysis of RIP3 immu-
nocomplex isolated from HSV-1-infected L929 cells and identi-
fied ICP6 as the highest-affinity RIP3-binding protein among all
HSV-1 viral proteins (Figure 4C). Noticeably, ICP6 is a leaky b
protein (Goldstein and Weller, 1988b) encoded by UL39 gene
and contains an RHIM-like domain (Figure 4D) (Lembo and
Brune, 2009). A significant amount of ICP6 has been synthesized
4 hr after HSV-1 infection, and the amount of ICP6 correlatedwell
with HSV-1-induced necroptosis (Figures S5A and S5B).
Toverify the involvementof ICP6and itsRHIMdomain inHSV-1-
induced necroptosis, Flag-tagged WT ICP6 and RHIM-mutated
ICP6 were delivered into L929 cells by a lentiviral vector. The
overexpression of ICP6 resulted in L929 cell death, whereas the
overexpression of its RHIM mutant did not (Figure 4E). The ICP6-
induced cell death was not inhibited but enhanced by zVAD, indi-
cating that the cell death is necroptosis (Figure 4E). ICP6-induced
cell death has nothing to do with TNF autocrine (Figure S5C). We
further tested the effect of ICP6 overexpression in RIP1 KO, RIP3
KO, andMLKL KO L929 cells and found that as with HSV-1 infec-
tion, shown in Figures 3B and 3C, ICP6-induced necroptosis was
partially blockedbyRIP1deletionandcompletely blockedbyRIP3
or MLKL deletion (Figure 4F). The necrosome formation and RIP3
phosphorylation at T231/S232 were also observed in ICP6-
induced cell death (Figure 4G). Thus, ICP6 overexpressionmimics
HSV-1 infection in the induction of necroptosis.
To confirm that ICP6 is indeed required for HSV-1 to induce
necroptosis, we employed a HSV-1mutant termed ICP6D (Gold-
stein and Weller, 1988a) whose ICP6 gene was deleted. We in-
fected WT and RIP3 KO L929 cells with HSV-1 or ICP6D and
measured their cell viabilities and HSV-1 gD protein levels. The
deletion of ICP6 significantly reduced RIP3-dependent necrop-
tosis (Figure 4H). Meanwhile, HSV-1 propagation significantly
increased (Figure S5D). To determine the function of ICP6
RHIM domain in HSV-1-induced necroptosis in vivo, we gener-
ated ICP6 RHIM mutant HSV-1 via pHSV-1 BAC (F strain) (Li
et al., 2011). Unlike ICP6D, the propagation ability of this mutant
virus (ICP6 RHIMmut HSV-1) is comparable to that of WT control
(HSV-1 BAC [F strain]). The ICP6 RHIMmut HSV-1 cannot induce
necroptosis in L929 cells (Figure 4I). The mutation of ICP6 RHIMat T231/S232 sites in an RHIM-dependent manner. RIP3 KO L929 cells stably
tor), Myc-tagged ICP6, or Myc-tagged RHIM-mutated ICP6 in the presence of
anti-Flag M2 beads. The total cell lysates and immunoprecipitates were im-
and RIP3 KO L929 cells were infected with HSV-1 (20 moi) and ICP6D HSV-1
gher dose of ICP6D was used because under this experimental condition the
hat in HSV-1-infected RIP3 KO cells (Figure S5D).
cell death. WT and RIP3 KO L929 cells were infected with HSV-1 BAC (F strain)
cell viability was determined.
escribed in Figure 1A, and viral titer was determined by a standard viral plaque
are representative of three independent experiments (A, B, and E–J). See also
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domain largely eliminated RIP3-mediated restriction on HSV-1
propagation in L929 cells (Figures 4J and S5E). A similar result
was obtained when low-dose (1 moi) HSV-1 was used in infec-
tion (Figure S5F). Collectively, our data demonstrated that the in-
duction of necroptosis by HSV-1 is largely dependent on the
RHIM domain of ICP6.
ICP6 Directly Interacts with RIP1 and RIP3
Since ICP6 RHIM domain is necessary for its overexpression-
induced cell death, we tested whether ICP6 interacts directly
with RIP1 and RIP3. Flag-ICP6 was expressed in WT, RIP1
KO, or RIP3 KO L929 cells, and its association with RIP1 and
RIP3 in those cells was determined by co-immunoprecipitation
(co-IP). ICP6 interacted with both RIP1 and RIP3 in WT cells,
RIP3 in RIP1 KO cells, and RIP1 in RIP3 KO cells (Figure 5A).
By expressing RHIM-mutated ICP6 (ICP6 RHIMmut), N-terminal
domain (ND), ND with RHIM mutation (ND RHIMmut), and C-ter-
minal R1 homology domain (RD) (Figure 5B), aswell asMyc-RIP1
or Myc-RIP3 in different combinations in HEK293T cells, we
show that the RHIM domain but not the RD in ICP6 is indispens-
able for ICP6 to interact with RIP1 and RIP3 (Figures 5C and 5D),
and the RHIM domain in RIP1 and RIP3 is also required for their
interaction with ICP6 (Figures 5E and 5F).
ICP6 Homo-Interaction Initiates the Necroptotic
Process
Although the ND only of ICP6 can interact with RIP1 and RIP3
(Figures 5C and 5D), we found that none of the ND, ND RHIMmut,
and RD overexpression can initiate necroptosis in L929 cells (Fig-
ure 6A). As it is known that TNF-induced necrosis is initiated by
the formation of RIP1-RIP3 hetero-interaction and then RIP3-
RIP3 homo-interaction (Wu et al., 2014), we reasoned that ICP6
might form dimers/oligomers and then recruit RIP1 and RIP3 or
RIP3 and RIP3 to initiate a similar necroptotic process. To test
this possibility, we co-expressed Flag-tagged ICP6 or truncated
ICP6 with Myc-tagged ICP6 in HEK293T cells and analyzed the
protein interactions between ICP6 and ICP6 or its mutants. We
found that Flag-ICP6 interacted with Myc-ICP6 in a C-terminal
RD- but not RHIM-dependent manner (Figure 6B). Consistently,
RD alone is sufficient to executeRDhomo-interaction (Figure 6C).
Since neither the ND nor RD alone is sufficient to trigger nec-
roptosis (Figure 6A), it is possible that the RD in ICP6 is respon-
sible for the interaction between ICP6 proteins and the ND can
initiate necroptotic signal from ICP6 complex. To test this hypoth-
esis, we determined whether artificial dimers of ICP6 ND would
lead to necroptosis. We used 4-hydroxytamoxifen (4-OHT) to
induce the hormone-binding domain G521R (HBD*)-based dimer
formation to address the question (Chen et al., 2014). We fused
HBD* to the C terminus of ICP6 ND (termed ND-HBD*) or ICP6
ND RHIM mutant (termed ND RHIMmut -HBD*) and expressed
them in TNFR1 KO L929 cells, in which the influence of TNF auto-
crine on cell death can be well avoided. After 4-OHT or 4-OHT
plus zVAD being added, TNFR1 KO cells expressing ND-HBD*
underwent cell death, whereas the control cells did not, demon-
strating that HBD*-mediated interaction of ICP6 ND is sufficient
to trigger cell death (Figure 6D). As anticipated, the RHIM domain
of ND is required for its function. Taken together, these data sug-
gest that the formation of dimers or oligomers of ICP6s initiates
RIP1-RIP3 hetero- and RIP3-RIP3 homo-interaction.236 Cell Host & Microbe 17, 229–242, February 11, 2015 ª2015 ElseHSV-1-Induced Necroptosis Is Initiated through Both
RIP1-Dependent and RIP1-Independent Mechanisms
We then explored the partial dependence of HSV-1-induced ne-
crosis on RIP1. As ICP6 can directly interact with both RIP1 and
RIP3, an ICP6 dimer/oligomer might recruit RIP1 and RIP3 to
form RIP1-RIP3 interaction. In the meantime, an ICP6 dimer/
oligomer might directly recruit more than one RIP3 to initiate
RIP3-RIP3 interaction. Indeed, sequential immunoprecipitations
detected both ICP6-RIP1-RIP3 and ICP6-RIP3-RIP3 complexes
(Figure 7A).
The co-existence of ICP6-RIP1-RIP3 and ICP6-RIP3-RIP3
complexes still cannot explain well the partial dependence on
RIP1 in HSV-1-induced necroptosis, because the formation of
ICP6-RIP3-RIP3 should be able to largely overcome the effect
of RIP1 knockout unless there is a preference of the formation
of ICP6-RIP1-RIP3 complex. To evaluate this possibility, we
compared ICP6’s affinity to RIP1 and RIP3. Flag-ICP6, HA-
RIP1, and HA-RIP3 were individually expressed in HEK293T
cells, and the binding of ICP6 to RIP1 and RIP3 were compared
by an in vitro pull-down assay. When comparable amounts of
HA-RIP1 and HA-RIP3 are used, ICP6 pulls down much more
RIP1 than RIP3 (Figure 7B), indicating that affinity of ICP6 to
RIP1 is much higher than to RIP3. High affinity between ICP6
and RIP1 makes the formation of ICP6-RIP1-RIP3 quicker than
that of ICP6-RIP3-RIP3, which explains the partial dependence
on RIP1 in HSV-1-induced necroptosis.
RIP3 Restricts HSV-1 Propagation in Mice
To determine the requirement of RIP3 in host defense against
HSV-1 infection in vivo, we infected WT and RIP3/ mice with
WT HSV-1 via the intravenous (i.v.) route and found RIP3/
mice were more sensitive to HSV-1-induced death (Figure 7C).
In contrast, there is no significant difference between WT and
RIP3/ mice in virus-induced death when ICP6D HSV-1 was
used (Figure 7D), indicating that the difference in mortality be-
tween HSV-1-infected WT and RIP3/ mice is an ICP6-depen-
dent pathogenesis process.
Consisting with the data of mortality, RIP3/ mice exhibited
more severe body weight loss in comparison with WT mice (Fig-
ure 7E); the levels of HSV-1 DNA in the brain of RIP3/ mice
were higher than those of WT mice (Figure 7F). In addition, we
also found that RIP3/ mice exhibited higher viral loads in tri-
geminal ganglia (TG) than WT mice when the mice were inocu-
lated via cornea (Figure 7G).
To examine the role of ICP6 RHIM in HSV-1 pathogenesis in
mice, ICP6 RHIMmut HSV-1 and its WT counterpart were used
to infect WT mice via i.v. injection. The viral loads in brain and
TG were determined (Figures 7H and 7I). ICP6 RHIMmut HSV-1
propagated more efficiently than WT HSV-1 in WTmice. Consis-
tently, ICP6 RHIMmut HSV-1 infection also leads to higher
lethality in WT mice (Figure 7J). These data demonstrate that
RIP3 senses RHIM of ICP6 to restrict HSV-1 propagation inmice.
DISCUSSION
HSV-1 infection leads to RIP3-dependent necroptosis in murine
cells, which restricts HSV-1 propagation in mice. Our model of
ICP6-initiated necroptosis is as follows: ICP6 forms dimers/oligo-
mers via its C-terminal RD; the ICP6 RHIMs in the dimer/oligomervier Inc.
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Figure 5. ICP6 Directly Interacts with RIP1 and RIP3
(A) ICP6 directly interacts with endogenous RIP1 and RIP3. WT, RIP1 KO, and RIP3 KO L929 cells were infected with lentiviral virus encoding nothing (Vector) or
Flag-tagged ICP6 for 36 hr and immunoprecipitated with anti-Flag M2 beads. The immunoprecipitates and whole-cell lysates were analyzed by immunoblotting
to determine the protein levels of RIP3 and RIP1.
(B) Schematic representation of WT and mutated ICP6. ICP6-RHIMmut, CP6 containing RHIM mutation; ND, N-terminal domain of ICP6; ND-RHIMmut, ND
containing RHIM domain mutation; RD, C-terminal R1 homology domain of ICP6.
(C)Mapping the RIP1-binding domain in ICP6. HEK293T cells were co-expressedwithMyc-taggedmRIP1 and Flag-tagged ICP6 or its differentmutants for 36 hr.
Co-IP assay was performed with anti-Flag M2 beads.
(D) Mapping the RIP3-binding domain in ICP6. The experiments were performed similarly as in (C), except that Myc-tagged mRIP3 was used.
(E) RIP1 interacts with ICP6 in an RHIM-dependentmanner. Flag-taggedWTor RHIM-mutatedmRIP1was co-expressedwithMyc-tagged ICP6 in HEK293T cells
for 36 hr. Co-IP assay was performed with anti-Flag M2 beads.
(F) RIP3 interacts with ICP6 in an RHIM-dependent manner. The same as in (E), except that Flag-tagged mRIP3 was used instead of Flag-tagged mRIP1.recruit RIP1 and RIP3 or two RIP3 to result in RIP1-RIP3 hetero-
interaction or RIP3-RIP3 homo-interaction; RIP1-RIP3 hetero-
interaction favors further recruitment of additional RIP3 andCell Host &thus also leads to RIP3-RIP3 homo-interaction (Wu et al., 2014);
and the pathway downstream of RIP3 is the same as that in
TNF-induced necroptosis, which involves recruiting MLKL byMicrobe 17, 229–242, February 11, 2015 ª2015 Elsevier Inc. 237
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Figure 6. ICP6 Homo-Interaction Initiates
Necroptotic Process
(A) The abilities of different ICP6 mutants in
inducing cell death. L929 cells were infected with
lentiviruses encoding nothing (Vector), ICP6, ICP6
RHIMmut, ND, NDRHIMmut, or RD for 60 hr, and the
cell viability was determined (left panel). The pro-
tein amounts of ICP6 and its mutants were deter-
mined by immunoblotting (right panel).
(B) ICP6 forms dimers or oligomers via its C-ter-
minal RD. Flag-tagged ICP6 or its mutant was co-
expressed with Myc-tagged ICP6 in HEK293T
cells for 36 hr. Co-IP assay was performed with
anti-Flag M2 beads.
(C) C-terminal RD alone is sufficient to form di-
mers/oligomers. Flag-tagged RD of ICP6 was co-
expressed with nothing or Myc-tagged RD in
HEK293T cells for 36 hr. Co-IP assay was per-
formed with anti-Myc beads.
(D) Artificially forced dimerization of ICP6 ND leads
to necroptotic cell death in an RHIM-dependent
manner. TNFR1/ L929 cells stably expressing
Flag-tagged ND-HBD* or ND RHIMmut-HBD* were
treated with EtOH (ethanol, control), EtOH+zVAD,
4OHT (4-hydroxytamoxifen), and 4OHT + zVAD for
72 hr, and the cell viability was determined (left
panel). The protein amounts of Flag-tagged ND-
HBD* and ND RHIMmut-HBD* (right panel) were
determined by immunoblotting.
Data are representative of the mean ± SD of trip-
licate wells (A and D), and similar results were
obtained from three independent experiments.RIP3 and the translocation of MLKL to plasma membrane and
subsequent membrane disruption (Figure S7A).
ICP6 in HSV-1 has been shown to be important for HSV-1
propagation especially in non-dividing cells (Goldstein and
Weller, 1988a, 1988b). ICP6D HSV-1 replicated more slowly
than WT HSV-1 in culture cells, and the growth rate of ICP6D
HSV-1 can be restored in cells expressing ICP6. The RHIM
domain in ICP6 is dispensable for HSV-1 propagation because
the propagation of ICP6 RHIMmut HSV-1 is the same as WT
HSV-1, and the replication rate of ICP6D HSV-1 in cells express-
ing RHIM-mutated ICP6 is comparable to that in cells expressing
WT ICP6 (Figure S5G). The catalytic activity of ICP6 is important
for HSV-1 propagation because the activity-deficient mutant of238 Cell Host & Microbe 17, 229–242, February 11, 2015 ª2015 Elsevier Inc.ICP6 (ICP6-C793A) cannot restore the
growth rate of ICP6DHSV-1 (Figure S5G).
Overexpression of ICP6-C793A still can
induce cell death in L929 cells, indicating
that ICP6’s enzymatic activity is not
required for ICP6-induced necrosis (Fig-
ure S5H). ICP6 can block DR-induced
apoptosis by interacting with caspase-8
(Dufour et al., 2011). We were able to
see the inhibition of caspase-8 by ICP6
in L929 cells (data not shown). Since inhi-
bition of caspase-8 promotes necropto-
sis, the inhibiting effect on casapse-8 by
ICP6 should further enhance necroptosis.
Although ICP6-induced necroptosis doesnot require DAI (Figure S4G), ICP6 still might have functional link-
age with DAI, since ICP6 can inhibit DAI overexpression-induced
NF-kB activation in an RHIM-dependent manner (data not
shown) and DAI can suppress HSV-1 replication (Pham et al.,
2013). ICP10, the R1 subunit of HSV-2 RNR, also contains an
RHIM-like domain and an R1 domain (Lembo and Brune,
2009). Similar to HSV-1, HSV-2 can also induce RIP3-dependent
cell death (Figure S2G).
Different from ICP6, the viral inhibitor of RIP activation (vIRA),
which is an RHIM-containing protein encoded by the M45 gene
of MCMV, has been reported to be catalytically inactive (Lembo
and Brune, 2009). It is important to note that ICP6 overexpres-
sion triggers necroptosis in L929 cells whereas vIRA does not
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Figure 7. HSV-1-Induced Necroptosis Is Initiated through Both RIP1-Dependent and Independent Mechanisms, and RIP3 Restricts HSV-1
Propagation in Mice
(A) ICP6 can initiate both RIP1-RIP3 hetero-interaction and RIP3-RIP3 homo-interaction. HEK293T cells were transfected with expression vectors as indicated,
and a sequential immunoprecipitation with anti-Flag and anti-HA was performed as described in the Supplemental Experimental Procedures.
(B) ICP6 has higher affinity for RIP1 compared with RIP3. The in vitro pull-down assay was performed as described in Experimental Procedures.
(C) WT and RIP3/ mice were infected with HSV-1 (1 3 107 pfu) via i.v. and tested for survival rate.
(D) WT and RIP3/ mice were infected with ICP6D HSV-1 (1 3 107 pfu) via i.v. and tested for survival rate. ns, no significant difference.
(E) WT and RIP3/ mice were infected with HSV-1 (1 3 107 pfu) via i.v., and body weight losses (4 days after infection) were recorded.
(F) WT and RIP3/ mice were infected with HSV-1 (1 3 107 pfu) via i.v., and HSV-1 genomic DNA levels in the brains of infected mice (harvested 3 days after
infection) were measured by qPCR analysis.
(G) WT and RIP3/ mice were anesthetized and infected with HSV-1 (5 3 106 pfu/eye) on the right eyes following scarification (20 times) of the cornea with a
needle. Three days after infection, trigeminal ganglia (TG) were isolated from mice and tested for HSV-1 genomic DNA levels by qPCR analysis.
(H) WT mice were infected with 1 3 107 pfu ICP6 RHIMmut HSV-1 or its WT counterpart via i.v., and HSV-1 genomic DNA levels in the brains of infected mice
(harvested 2 days after infection) were measured by qPCR analysis.
(I) WT mice were infected with 1 3 107 pfu ICP6 RHIMmut HSV-1 or its WT counterpart via i.v., and HSV-1 genomic DNA levels in the trigeminal ganglia (TG) of
infected mice (harvested 2 days after infection) were measured as in (F).
(J) WT mice were infected with 1 3 107 pfu ICP6 RHIMmut HSV-1 or its WT counterpart via i.v. and tested for survival rate.
Data are represented as mean ± SEM (E–I). *p < 0.05, **p < 0.01 (Student’s t test). The survival curve was generated by Kaplan-Meier methods.
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(Figure S6A). While vIRA can disrupt the RHIM-dependent RIP1-
RIP3 kinase complex (Upton et al., 2010) and thus inhibits TNF-
induced necroptosis in L929 cells, ICP6 cannot (Figure S6B).
Similar to ICP6, vIRA forms dimers/oligomers independent of
the RHIM domain (Figure S6C) and interacts with RIP3 via the
ND (1–278) in an RHIM-dependent manner (Figure S6D).
Different from ICP6, vIRA exhibits an inhibitory effect on the for-
mation of murine RIP1-RIP3, RIP3-RIP3, or RIP3-MLKL com-
plexes (Figure S6E). Consistently, when vIRA was co-expressed
with murine RIP3 in HEK293T cells, the autophosphorylation
of RIP3 was markedly reduced (the shift bands of RIP3 and
p-RIP3 in lanes 2 and 8 of the whole-cell lysates shown in Fig-
ure S6D). ICP6’s enhancing effect on RIP3 phosphorylation
(band shift) is difficult to detect in this system, since ectopically
expressed murine RIP3 in 293T cells already has basal phos-
phorylation. We found that the difference between ICP6 and
vIRA in inducing necroptosis in L929 cells lies in their distinct
RHIM domains, since the change of the RHIM domains of ICP6
and vIRA (ICP6vIRA-R and vIRAICP6-R) with each other (Figure S6F)
blocked ICP6’s function to induce necrosis while enabling vIRA
to do so (Figure S6G). These data demonstrate that there are
at least two different RHIM-RHIM interactions that play opposite
roles in RIP3-mediated necroptosis. The anti-necroptosis RHIM
could be evolved from the pro-necroptosis RHIM, since this
change allows the virus to evade the restriction by necroptosis.
While our manuscript was under revision, Wang et al. reported
that HSV-1 can trigger RIP3/MLKL-dependent necrosis (Wang
et al., 2014b), which is similar to our observation in mouse cells.
However, the authors of that report overlooked the fact that
HSV-1 infection did not induce RIP3-dependent necroptosis in
human cells. In addition to HT-29 cells, we also obtained data
from another human cell line, HeLa. HeLa cells do not express
RIP3 and undergo apoptosis upon TNF treatment. Since ectopic
expression of RIP3 in HeLa cells converts TNF-induced apo-
ptosis to necroptosis (He et al., 2009), we infected RIP3-express-
ing and control HeLa cells with HSV-1 and found that the death of
RIP3-expressing cells was slightly more than that of control cells.
However, the enhancing effect of RIP3 on cell death was inde-
pendent of ICP6, because the same result was obtained when
ICP6D HSV-1 was used (Figure S2H). Since the autocrine effect
of TNF upon HSV-1 infection contributes a little in HSV-1-
induced cell death (Figure 3A), we speculated that the expression
of RIP3 in HeLa cells enhanced TNF autocrine-induced cell
death. The data obtained using HeLa cells support the conclu-
sion that HSV-1 cannot induce necroptosis in human cells.
ICP6 overexpression cannot induce cell death in HT-29 cells,
but we still detected RHIM-dependent interaction between
ICP6 and human RIP1 or human RIP3 (data not shown), suggest-
ing that the interaction with ICP6 does not promote human RIP1
and/or human RIP3 to mediate necroptotic signals. Moreover,
ICP6 can depend on the RHIM domain to inhibit TNF-induced
necroptosis in human HT-29 cells (Figure S7B), which is contrary
to the result in mouse L929 cells (Figure S7C). Consistently,
HSV-1 pre-treatment suppresses TNF-induced necrosis in HT-
29 cells (Figure S7D). In a companion to our study, Guo et al. re-
ported the same function of ICP6 in human cells (Guo et al.,
2015). The minor structural differences between human and
mouse RHIM domains should be responsible for the pro- or
anti-necroptosis effect of ICP6. It is known that the propagation240 Cell Host & Microbe 17, 229–242, February 11, 2015 ª2015 Elseof HSV-1 in mouse cells is less efficient than in human cells. The
induction of necroptosis by ICP6 in mouse but not in human cells
might partly account for this phenomenon. Since HSV-1 is a nat-
ural human pathogen, we speculate that the RHIM of HSV-1 has
already evolved to evade human RIP1 and human RIP3-medi-
ated necroptosis, but has not done so to evade mouse cells.
Sensing ICP6 by RIP1 and RIP3 might also serve as a ‘‘species
barrier’’ to limit HSV-1’s natural infection in mouse organism.
EXPERIMENTAL PROCEDURES
Cell and Cell Lines
L929, HEK293T, HeLa, and Vero cells were obtained from ATCC. RIP1 KO,
RIP3 KO, MLKL KO, and 3 3 Flag-tagged MLKL-reconstituted MLKL KO
L929 cells were established as described (Chen et al., 2014). RIP3 KO
HT-29 cells, TNFR1 KO, DAI KO, cGAS KO, and RIG-I KO L929 cells were
generated by using CRISPR/Cas9 or TALEN gene editing technique as
described in the Supplemental Information. The KO cells were determined
by the sequencing of targeted loci. RIP3+/+ and RIP3/ MEFs were isolated
from mouse embryos at 13.5 dpc. NIH 3T3 A and N cells were described in
our previous work (Zhang et al., 2009).
Preparations of Viruses
HSV-1 (KOS strain) and HSV-2 (G strain) were obtained from ATCC, and GFP-
HSV-1 (F strain) was generated as previously described (Li et al., 2011); all
were propagated in Vero cells. ICP6D HSV-1 (KOS strain) and its WT counter-
part were provided by Dr. Sandra Weller (University of Connecticut Health
Center). ICP6D HSV-1 was propagated in Vero cells stably expressing ICP6.
ICP6 RHIMmut HSV-1 was generated via pHSV-1 BAC (F strain) as previously
described (Li et al., 2011). VSV- and NDV-GFP were provided by Dr. Zhengfan
Jiang (Peking University).
Reagents, Antibodies and Constructs
The detailed information of reagents, antibodies, and constructs is described
in the Supplemental Experimental Procedures.
Cell Viability Assay
The cell viabilities of L929, NIH 3T3, HT-29, and HeLa cells were determined by
flow cytometry with two parameters: plasma membrane integrity and cell size.
The plasma membrane integrity was tested by the ability of cells to exclude PI.
Cells were trypsinized and collected with the dead cells in the media by centri-
fugation, washed once with PBS, and resuspended in PBS containing 5 mg/ml
PI. The levels of PI incorporation were quantified on a FACScan flow cytome-
ter. The cell viability ofMEFswas determined byMTT assay as described in the
Supplemental Experimental Procedures.
HSV-1 and HSV-2 Titration
For the quantification of HSV-1 and HSV-2, viral plaque assay was performed
on Vero cells. The detailed method is described in the Supplemental Experi-
mental Procedures.
Confocal Microscopy
Confocal microscopy analysis was performed as previously described (Chen
et al., 2014).
Sequential Immunoprecipitation
HEK293T cells were transfected as indicated in Figure 7A for 36 hr. Then cells
were harvested and the whole-cell lysates were subjected to the first round of
immunoprecipitation with anti-Flag M2 beads. After this, the immunoprecipi-
tates were eluted with the 3 3 Flag peptide and diluted with 1 ml of the lysis
buffer. This solution was then subjected to the second round of immunopre-
cipitation with anti-HA beads, followed by immunoblotting with corresponding
antibodies.
In Vitro Pull-Down Assay
HEK293T cells were transfected with an expression vector encoding nothing
(empty vector), Flag-ICP6, HA-mRIP1, or HA-mRIP3 for 36 hr. The cellsvier Inc.
were lysed and the whole-cell lysates from the cells expressing HA-mRIP1 or
HA-mRIP3were diluted with the lysates from empty vector-transfected cells to
equalize the concentration of HA-mRIP1 and HA-mRIP3 in the two cell lysates.
Equal volumes of the equalized HA-mRIP1- and HA-mRIP3-containing cell
lysates were mixed with the cell lysates from the cells transfected with vector
or Flag-ICP6-expressing plasmid, as indicated in Figure 7B. The mixed cell ly-
sates were then subjected to immunoprecipitation with anti-Flag M2 beads,
followed by immunoblotting analysis.
Viral Infection in Mice
Mice were housed in a specific pathogen-free environment. All experiments
were conducted in compliance with the regulations of Xiamen University.
Mice were infected i.v. with HSV-1. The detailed method is described in the
Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and two movies and can be found with this article online at
http://dx.doi.org/10.1016/j.chom.2015.01.002.
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